Loss per Share

9 Months Ended

Oct. 26, 2025

The computation of basic and diluted loss per share was as follows:


	Three Months Ended				Nine Months Ended
(in thousands, except per share data)	October 26, 2025		October 27, 2024		October 26, 2025		October 27, 2024
Net loss	$	(2,862)	$	(7,586)	$	(10,581)	$	(201,040)

Weighted-average shares outstanding–basic	87,682		75,319		86,944		68,385




Weighted-average shares outstanding–diluted	87,682		75,319		86,944		68,385

Loss per share:
Basic	$	(0.03)	$	(0.10)	$	(0.12)	$	(2.94)
Diluted	$	(0.03)	$	(0.10)	$	(0.12)	$	(2.94)

Anti-dilutive shares not included in the above calculations:
Share-based compensation	2,363		431		2,126		1,023


Warrants	2,697		8,573		2,697		8,573
Total anti-dilutive shares	5,060		9,004		4,823		9,596

Basic earnings or loss per share is computed by dividing net income or loss available to common stockholders by the weighted-average number of shares of common stock outstanding during the reporting period. Diluted earnings or loss per share incorporates the incremental shares issuable, calculated using the treasury stock method, upon the assumed exercise of non-qualified stock options and the vesting of restricted stock units, market-condition restricted stock units and financial metric-based restricted stock units if certain conditions have been met, but excludes such incremental shares that would have an anti-dilutive effect. Due to the Company's net loss for the three and nine months ended October 26, 2025 and October 27, 2024, all shares underlying stock options and restricted stock units were considered anti-dilutive.

Any dilutive effect of the 2027 Notes, 2028 Notes and 2030 Notes (as defined in Note 8, Long-Term Debt) is calculated using the if-converted method. For the three and nine months ended October 26, 2025 and October 27, 2024, the 2027 Notes were excluded from diluted shares outstanding due to net loss in such reporting periods. For the three and nine months ended October 27, 2024, the 2028 Notes were excluded from diluted shares outstanding due to net loss in such reporting periods. For the three and nine months ended October 26, 2025, the 2030 Notes were excluded from diluted shares outstanding because the conversion price exceeded the average market price of the Company's common stock for the reporting periods and due to net loss in such reporting periods.

Any dilutive effect of the Warrants (as defined in Note 8, Long-Term Debt) is calculated using the treasury-stock method. For the three and nine months ended October 26, 2025 and October 27, 2024, the Warrants were excluded from diluted shares outstanding due to net loss in such reporting periods.